PRPH (ProPhase Labs Inc) Gross Profit Rate

Official company branding of ProPhase Labs Corp (PRPH)

Stable turnover of over-the-counter brands supports ProPhase Labs, Inc. during periods of transformation. The core strategy focuses on the synthesis of genomic sequencing with Nebula Genomics AI platforms, creating high customer retention value. Gross profit margins confirm the impact of capacity underutilization during the transition to genomics. The value of 0.00 serves as the current metric level, capturing the real operational efficiency of management.

ProPhase Labs (PRPH) Gross Profitability: for the period 07/04/2022 - 01/10/2026

Comprehensive metric breakdowns and analytics for ProPhase Labs, Inc. (PRPH)

- current price and projected stock value:
- business market valuation indicators:
Basic company analysis:ProPhase Labs, PRPH
Signature product of ProPhase Labs Corp

Gross margin measures the share of profit after deducting direct production costs, allowing for an assessment of operational efficiency and the business's ability to generate cash flow. For ProPhase Labs, Inc. (PRPH), diversification between laboratory diagnostics and genomic therapies stabilizes the gross profit margin, confirming the business model's resilience to industry cycles and serving as an indicator of the company's fundamental reliability.